Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

End-to-End Mandarin Speech Reconstruction Based on Ultrasound Tongue Images Using Deep Learning.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2025

Same author

Hybrid Quantum Deep Learning With Superpixel Encoding for Earth Observation Data Classification.

IEEE transactions on neural networks and learning systems·2025

Same author

Comparison of different approaches applied for surgical correction of partial anomalous pulmonary venous connection.

Cardiology in the young·2025

Same author

Enhanced heart sound anomaly detection via WCOS: a semi-supervised framework integrating wavelet, autoencoder and SVM.

Frontiers in neuroinformatics·2025

Same author

Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models.

GeroScience·2025

Same author

Developing Soluplus®-Based Microparticle Amorphous Solid Dispersions with High Drug Loading for Enhanced Celecoxib Dissolution via Electrospraying.

AAPS PharmSciTech·2025

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Immunotherapy for glioma: Current management and future application.

Shengchao Xu¹, Lu Tang², Xizhe Li²

¹Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, 410008, Hunan, People's Republic of China.

|February 12, 2020

Summary

Glioma immunotherapy shows promise for brain tumors, but current clinical trials reveal limited efficacy. Further research is essential to develop effective novel therapeutic strategies for glioma patients.

Keywords:

Checkpoint Glioma Immunotherapy Oncolytic virus Vaccine

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Experiment Videos

Last Updated: Dec 28, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Area of Science:

Neuro-oncology
Cancer immunology
Brain tumor research

Background:

Gliomas are primary brain tumors originating from neuroglial progenitor cells.
Conventional treatments like surgery, chemotherapy, and radiotherapy offer limited improvements in glioma patient prognosis.
The discovery of central nervous system lymphatics has opened avenues for immunotherapy to overcome the blood-brain barrier.

Purpose of the Study:

To review the current management of gliomas.
To assess previous studies on various immunotherapies for gliomas.
To identify novel therapeutic strategies and drugs for future glioma treatment.

Main Methods:

Review of existing literature on glioma management.
Analysis of clinical trial data for immunotherapies in gliomas.
Identification of drugs that have undergone clinical trials for glioma.

Main Results:

Immunotherapy presents a promising strategy for glioma treatment due to its potential to cross the blood-brain barrier.
Despite ongoing research, many associated clinical trials for immunotherapies in gliomas are not yet completed.
Several drugs evaluated in clinical trials show limited efficacy in treating gliomas.

Conclusions:

Current immunotherapies have demonstrated limited efficacy in glioma treatment.
Novel therapeutic approaches require further investigation and evaluation.
Additional studies are crucial to advance glioma treatment strategies.